Ipol vial 5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F24K1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,923
Award facts
- Contract value 100% obligated
- $10,923.45 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $10,923.45 to AmerisourceBergen Drug Corp for the supply of Ipol vial 5ml, a polio vaccine, on January 13, 2026, with an ultimate completion date of January 14, 2026. This non-set-aside contract represents a firm fixed-price purchase order executed through the company's existing indefinite delivery contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor, with its parent company being Cencora, Inc. (formerly doing business as AmerisourceBergen). The place of performance is located in Conshohocken, Pennsylvania.
This delivery order exemplifies the routine pharmaceutical supply operations conducted under the DLA Troop Support Medical indefinite delivery contract, which provides a comprehensive global pharmaceutical support vehicle for military healthcare programs. The contract vehicle enables efficient delivery of vaccines, medications, and medical supplies to support the Defense Health Agency and other federal healthcare systems worldwide. AmerisourceBergen's significant pharmaceutical distribution capabilities and established presence in the federal supply chain position it as a critical vendor for military medical procurement needs, particularly for vaccines and specialty medications required across the military treatment facility network.
Quick answers
Who was awarded contract SPE2DR26F24K1?
SPE2DR26F24K1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 13, 2026.
How much is contract SPE2DR26F24K1 worth?
The government has obligated $10,923 on SPE2DR26F24K1.
Is contract SPE2DR26F24K1 an order under another contract?
Yes. SPE2DR26F24K1 is a delivery order under SPE2DR25D1047, an indefinite delivery contract.
Was contract SPE2DR26F24K1 competed?
The extent of competition for SPE2DR26F24K1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award